Trial Profile
A study to evaluate imaging changes by three-dimensional nail imaging by optical coherence tomography in patients with nail psoriasis following 6 month-therapy with Apremilast
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2017
Price :
$35
*
At a glance
- Drugs Apremilast (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Therapeutic Use
- 30 Jun 2017 New trial record
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism